Drawing for Serial No. 79404710

USPTO serial 79404710

Serial No. 79404710

Reviewed by CopyMark Law Group

Reg. 7854281Status 700Registered
Filing date
Status date
Registration date
Jul 8, 2025
Examiner
BLACK, MILDRED ELIZABETH
Law office
FILE REPOSITORY (FRANCONIA)

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with Serial No. 79404710?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Kathryn M. Eyster

Kathryn M. Eyster Tepper & Eyster, PLLC3724 Benson DriveRaleigh, NC 27609United States

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical preparations for the prevention and treatment of diseases and disorders of the alimentary tract and metabolism; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the blood and blood forming organs; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the cardiovascular system, musculoskeletal system, central nervous system, peripheral nervous system, genitourinary system and respiratory system; pharmaceutical preparations for the prevention and treatment of dermatological diseases and disorders, damaged skin and tissues; pharmaceutical preparations for the prevention and treatment of inflammation and inflammatory diseases and disorders; pharmaceutical preparations for the prevention and treatment of ophthalmological diseases and disorders; pharmaceutical preparations for the treatment and prevention of hormonal diseases and disorders; Pharmaceutical preparations for the treatment and prevention of infectious diseases and disorders and viral infections; pharmaceutical preparations for the prevention and treatment of oncological and auto-immune diseases and disorders; Pharmaceutical preparations, namely, cell based immune therapeutics for treatment of cancer, for treatment of immunological diseases, and treatment of infectious diseases.ACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Mar 5, 2026OPNXNOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB—
Feb 19, 2026FINVFINAL DECISION TRANSACTION PROCESSED BY IB—
Feb 18, 2026OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Feb 18, 2026OPNRNOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB—
Feb 4, 2026FICSFINAL DISPOSITION NOTICE SENT TO IB—
Feb 4, 2026FIMPFINAL DISPOSITION PROCESSED—
Oct 8, 2025FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Jul 8, 2025NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Jul 8, 2025R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
May 20, 2025NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
May 20, 2025PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
May 14, 2025NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Apr 17, 2025CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Apr 5, 2025RFNTREFUSAL PROCESSED BY IB—
Mar 27, 2025TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Mar 27, 2025CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Mar 27, 2025TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Mar 20, 2025RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Mar 20, 2025RFRRREFUSAL PROCESSED BY MPU—
Feb 13, 2025RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Feb 12, 2025CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 5, 2025DOCKASSIGNED TO EXAMINER—
Oct 15, 2024MAFRAPPLICATION FILING RECEIPT MAILED—
Oct 15, 2024NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Sep 24, 2024LIMILIMITATION FROM ORIGINAL APPLICATION ENTERED—
Sep 19, 2024REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance